Anvisa directors are threatened with death before the possibility of approving Covid vaccine for children

The five directors of Anvisa (National Health Surveillance Agency) were threatened with death if the approval of a vaccine against Covid-19 for children aged 5 to 11 occurs.

The threat was made by email this Thursday morning (28). She was not anonymous, but the agency is not sure if the name used is the real one.

Members of the board are Antonio Barra Torres (CEO), Meiruze Sousa Freitas (second board), Cristiane Rose Jourdan Gomes (third board), Rômison Rodrigues Mota (fourth board) and Alex Machado Campos (fifth board).

In addition to the principals, school institutions in the state of Paraná are also the target of the aforementioned death threats.

In the message, the sheet had access, the person says that if there is approval by Anvisa for vaccination in children, the child would be immediately removed from school and would not return.

“I’m taking the difficult attitude of removing him from the school environment to preserve my child’s safety. Making it clear to those responsible, from top to bottom: whoever threatens, whoever threatens my child’s physical safety will be killed,” he says the text.

“This is not a threat. It’s an establishment. I’m notifying you in writing because I don’t want complaints later,” he continues.

Anvisa said, in a note, that it immediately officiated to the police authorities and the Public Ministry, at the federal, state and district levels, among others, to adopt the appropriate measures.

There are still no requests from Anvisa to release the application of doses of vaccine against Covid-19 in children. Pfizer said it must ask the regulatory agency to apply the ComiRNAty vaccine to children in November.

“The submission of the request to Anvisa for the approval of the use of the ComiRNAty vaccine, from Pfizer/Biontech, for children between 5 and 11 years old should take place during the month of November 2021”, he said in a statement.

The Butantan Institute even asked for the release of Coronavac for children and adolescents aged 3 to 17 at the regulatory agency, but the approval was denied and the process ended in August.

The Ministry of Health plans to vaccinate children against Covid in 2022 if Anvisa approves the immunization. For this audience, the forecast is 70 million doses.